Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are pleased to announce that today the University of Oxford MRC Brain Network Dynamics Unit joins the Nuffield Department of Clinical Neurosciences (NDCN) as a sixth division.

Large group of people on steps of building

The MRC BNDU had its funding renewed earlier this year, and is developing its integrated approach to fundamental and translational neuroscience. NDCN as its new host department will be able to exploit existing collaborations with MRC BNDU researchers, as well as finding new ways to work together.

The MRC BNDU’s key strength is its focus on understanding and exploiting the moment-to-moment interactions between brain cells, particularly those involved in movement and memory. A deeper understanding of these circuits could help us develop interventions for when things go wrong in these brain mechanisms.

We in NDCN look forward to learning from the MRC BNDU’s exemplary approach to public engagement, staff development, data sharing and working with industry.

The Unit, led by Professor Peter Brown, will continue to have its main physical base next to the Department of Pharmacology on Mansfield Road. This will help to consolidate our foothold ‘down the hill’, first established by our Sleep and Circadian Neuroscience Institute, which is currently located in the Dunn School of Pathology.

Find out more at www.mrcbndu.ox.ac.uk/

Similar stories

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

COVID-19 infection has greater risk than vaccines of causing very rare neurological events

Research reveals risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between a core team of Professors Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Dr Mark Howe at Boston University and Professor Dinos Meletis at the Karolinska Institute, as well as collaborators Professor Yulong Li at Peking University and Dr Michael Lin at Stanford University.

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.

Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd

Mapping brain network activity from structural connectivity using deep learning

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.